Active Surveillance For Prostate Cancer: What You Need To Know

Introduction

Decision Making

Active Surveillance Protocol

Risks and Management

Overview and Ideal Candidates for Active Surveillance in Prostate Cancer

Active surveillance is a treatment strategy for prostate cancer, focusing on closely monitoring the disease rather than immediate intervention. This approach involves undergoing regular tests and screenings to watch for signs of progression.

Ideal candidates for this approach typically have:

  • Low-risk, localized prostate cancer
  • Small tumors confined to the prostate gland
  • A Gleason score less than 7
  • Low PSA levels (prostate-specific antigen)

This method is often considered by individuals looking to avoid the side effects of treatments like surgery or radiation therapy.

Active surveillance entails careful management of the condition through frequent check-ups and tests, ensuring that any changes in the state of the disease are promptly addressed.

Why Choose and Understanding the Results of Active Surveillance?

Active surveillance is often selected for conditions that are slow-growing and asymptomatic, providing an avenue to circumvent unnecessary treatments and their associated serious side effects.

The process involves:

  • Regular check-ups
  • Tests
  • Scans to monitor disease progression

Changes in the condition may lead to a reconsideration of treatment options. This strategy necessitates a commitment to frequent follow-up appointments to ensure close monitoring of the condition.

Active surveillance offers a way to monitor disease progression closely, potentially avoiding the side effects of treatments.

Find Top Cancer Clinical Trials

Choose from over 30,000 active clinical trials.

Monitoring Process and Procedures in Active Surveillance

Active surveillance involves closely monitoring a condition through regular check-ups and tests, rather than opting for immediate treatment. This method is often applied to slowly progressing conditions, such as certain types of cancer.

The process begins with baseline testing, where initial tests serve as a reference for future comparisons. These tests can encompass blood work, imaging scans, or biopsies.

Routine follow-up visits occur after the baseline test, with their frequency depending on the specific health situation, usually every 3-6 months. During these appointments, similar tests to those conducted at baseline are performed.

Doctors analyze results from the follow-up visits, comparing them against the baseline data. Changes in these comparisons may indicate a progression of the disease that could require a more aggressive form of intervention. Conversely, if no significant changes are observed over time, the active surveillance continues instead of transitioning towards more aggressive treatment options, which may have potential side-effects or risks. This cycle persists until significant progression is detected or another medical decision is influenced by factors such as age or overall health status.

In summary, the process includes:

  1. Baseline testing
  2. Routine follow-up visits and tests
  3. Comparison of new data to baseline
  4. Decision-making based on this comparison

Active surveillance involves a careful and monitored approach, focusing on the balance between intervention and observation.

Potential Risks and Treatment Options in Case of Cancer Progression

Cancer progression indicates the growth or spread of cancer, presenting various risks. Physical risks encompass increased pain, organ failure, and diminished physical function. Emotional risks include stress and anxiety.

A variety of treatment options exist for progressed cancer, such as:

  • chemotherapy,
  • radiation therapy,
  • surgery,
  • immunotherapy,
  • targeted therapy, and
  • palliative care.

Chemotherapy utilizes drugs to eliminate cancer cells throughout the body. Radiation therapy employs high-powered energy beams focused on specific areas to destroy cancer cells. Surgery involves the physical removal of the tumor.

Immunotherapy enhances the immune system's capability to combat cancer cells. Targeted therapies employ drugs specifically designed to attack particular characteristics of cancer cells that distinguish them from healthy cells.

Palliative care aims to improve quality of life by managing symptoms, such as pain or nausea, focusing on comfort rather than curing the disease.

Each treatment option offers a different approach to managing progressed cancer, highlighting the diverse strategies available in oncology.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top